|
|
|
Kenes UK Ltd, United Kingdom
2011-11-29 to 2011-11-30
Day 1 - Tuesday, 29th November 2011|
09:00 - 09:15 | Welcome Prof Ian Jacobs Vice-President and Dean of the Faculty of Medical and Human Sciences, The University of Manchester | 09:15 - 09:30 | Ovarian cancer – Overview of current diagnosis and management Mr Tim Mould Consultant Gynaecological Oncologist, UCH, UK | | 09:30 - 10:00 | Novel biomarkers Prof Robert Bast Professor Gynaecological Oncology, MD Anderson, USA | 10:00 - 10:30 | Refining ultrasound Prof Dirk Timmerman, Clinical Head of Gynaecology, University Hospitals Gasthuisberg Campus, Belgium | 10:30 - 10:45 | Oral presentation | 10:45 - 11:15 | Tea/Coffe Break & Exhibition/Poster Viewing | | 11:15 - 11:45 | Inherited risk Prof Simon Gayther Professor of Preventive Medicine, University of Southern California, USA | 11:45 - 12:15 | Acquired Risk - reproductive and lifestyle factors Dr Susanne Kruger-Kjaer Danish Cancer Registry, Denmark | 12:15 - 12:45 | Status of Risk Stratification Dr Paul Pharoah Senior Clinical Research Fellow University of Cambridge, Strangeways Research Laboratory, UK | 12:45 - 13:00 | Oral presentation | 13:00 - 14:00 | Lunch Break & Exhibiton/Poster Viewing | | 14:00 - 14:30 | PLCO Study (USA) Dr Christine Berg Obstetrics, Gynaecology & Infertility Advanced Healthcare Brookfield, NIH, USA | 14:30 - 15:00 | UKCTOCS STUDY (UK) Prof Usha Menon Professor of Gynaecological Cancer, UCL, UK | 15:00 - 15:30 | Oral presentation | 15:30 - 16:00 | Kentucky Utrasound Screening Dr Edward Pavlik University of Kentucky Chandler Medical Center-Markey Cancer Center, USA | 16:00 - 16:30 | Tea/Coffe Break & Exhibition/Poster Viewing | | 16:30 - 17:00 | ROCA and GOG0199 Screening Studies Dr Steve Skates Associate Professor of Medicine (Biostatistics), Harvard Medical School, USA | 17:00 - 17:30 | UK study - UKFOCCS Dr Adam Rosenthal Senior Lecturer Gynaecological Oncology, QMUL Medical School, Barts and the London NHS Trust, UK | 17:30 | Sum-up of day 1 |
Day 2 - Wednesday, 30th November 2011|
| 09:00 - 09:30 | Serious ovarian cancer – defining targets for early detection site of origin Dr Pat Brown Stanford University School of Medicine, USA | 09:30 - 10:00 | Lead time of screening Prof Ian Jacobs Vice-President and Dean of the Faculty of Medical and Human Sciences, The University of Manchester | 10:00 - 10:30 | Insights from BRCA mutation carriers Prof Christopher P. Crum Professor, Department of Pathology, Harvard Medical School Director, Womens and Perinatal Pathology, Brigham And Women's Hospital, USA | 10:30 - 10:45 | Oral presentation | 10:45 - 11:15 | Tea/Coffe Break & Exhibition/Poster Viewing | | 11:15 - 11:45 | Development of screening algorithms using longitudinal biomarkers Dr Steve Skates Associate Professor of Medicine (Biostatistics), Harvard Medical School, USA | 11:45 - 12:15 | Biomarker discovery Dr Anna Lokshin Associate Professor of Medicine with joint appointments as Associate Professor of Pathology and Ob/Gyn Reproductive Sciences Director of Luminex Core Facility, University of Pittsburgh, USA | 12:15 - 13:00 | Oral presentation | 13:00 - 14:00 | Lunch Break & Exhibiton/Poster Viewing | 14:00 - 17:30 | | This innovative meeting will include an interactive workshop of researchers from academia and industry, where the goal will be to address limitations of current discovery strategies for ovarian cancer biomarkers and explore possible solutions. | 17:30 | Close of conference |
|
|
|
|
|
|
Organized by:
|
|
Kenes UK Ltd |
|
Invited Speakers:
|
|
Mentioned below.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
To be annonced
|
|
|
|
|
|
Registration:
|
|
Can be completed online -
- Admission to lectures and demonstrations
- All course materials
- Coffee/tea and lunch
- Welcome Reception on 29 November 2011
- VAT
- Emailed, faxed or postmarked prior to 10 October 2011 - Full refund (less 10% administration fee)
- Emailed, faxed or postmarked from 10 October - 6 November - 50% refund (or 50% payment to be made to Kenes UK if fees not already paid at time of cancellation)
- Emailed, faxed or postmarked after 6 November - No refunds will be given (or 100% payment to be made to Kenes UK if fees not already paid at time of cancellation)
Registration Fees (in GBP including VAT)Fees apply to payments received prior to the indicated deadlines International Conference on Ovarian Cancer Screening 29-30 November 2011 • RCP, London | Early Registration Until 30/06/11 | StandardRegistration From 01/07/11 until 10/09/11 | Late Registration From 11/09/11 until 28/11/11 | Onsite Registration From 29/11/11 | Full Meeting: | Consultants /Nursing Consultants /Academics/ GPs /Managers | £385.00 | £405.00 | £435.50 | £487.00 | Trainees/ Junior Doctors/ Junior Scientists /Junior Nurses | £256.00 | £282.00 | £302.50 | £323.00 | Day Rate: | Consultants /Nursing Consultants /Academics/ GPs /Managers | £128.00 | £138.50 | £149.00 | £164.00 | Trainees/ Junior Doctors/ Junior Scientists /Junior Nurses | £92.50 | £97.50 | £102.50 | £108.00 |
Trainees/ Junior Doctors/ Junior Scientists /Junior Nurses rate: In order to obtain the special fee, an approval letter signed by the head of the department must accompany the registration form. Please email to ovarianscreening@kenes.com or fax to 0044 (0)20 7383 8040. The Conference Registration fees include: Disclaimer: Payment for early registration must be received by 30 June 2011 in order to benefit from the lower registration fees, standard payments by 10 September 2011, and late payment by 28 November 2011. Payment not received before the meeting is considered on-site and will be charged accordingly. Registration and payment should be made by 28 November 2011. After this date, the online system will be closed and registration will be only be available on-site. Cancellation Terms and Conditions: Notification of cancellation must be made in writing to the Meeting Secretariat, Kenes UK to ovarianscreening@kenes.com Registration cancellations will be accepted until 6 November 2011 with a refund as follows:
|
|
E-mail:
|
|
ovarianscreening@kenes.com
|
|
|
|
|
|
|
|